SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

Not exactly.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 46
Posts 6,123
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
TroyGould Advises Haitong International in its $190 Million Acquisition of Obagi Skincare Products Business "PR Newswire (US)" - 11/16/2017 1:00:00 PM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (Canada)" - 11/15/2017 8:00:00 AM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (US)" - 11/15/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2017 5:02:27 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (Canada)" - 11/14/2017 4:10:00 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (US)" - 11/14/2017 4:10:00 PM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (Canada)" - 11/14/2017 9:00:00 AM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (US)" - 11/14/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 7:47:10 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (Canada)" - 11/13/2017 7:35:00 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (US)" - 11/13/2017 7:35:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (Canada)" - 11/10/2017 7:00:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (US)" - 11/10/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/9/2017 7:54:54 AM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (Canada)" - 11/8/2017 6:02:00 PM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (US)" - 11/8/2017 6:02:00 PM
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery "GlobeNewswire Inc." - 11/8/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2017 5:29:18 PM
Valeant Shares Rise As It Makes Progress on Debt -- Market Talk "Dow Jones News" - 11/7/2017 8:36:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/7/2017 7:05:32 AM
Valeant Announces Third-Quarter 2017 Results "PR Newswire (Canada)" - 11/7/2017 7:00:00 AM
Valeant Announces Third-Quarter 2017 Results "PR Newswire (US)" - 11/7/2017 7:00:00 AM
Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals "PR Newswire (Canada)" - 11/6/2017 7:00:00 AM
Valeant Agrees To Sell Sprout Pharmaceuticals Subsidiary To Former Shareholders Of Sprout Pharmaceuticals "PR Newswire (US)" - 11/6/2017 7:00:00 AM
Bausch + Lomb And Nicox Announce FDA Approval Of VYZULTA™ (latanoprostene Bunod Ophthalmic Solution), 0.024% "PR Newswire (US)" - 11/2/2017 4:26:00 PM
JLS   Thursday, 11/09/17 03:27:34 PM
Re: JohnCM post# 3858
Post # of 3955 
Not exactly.

VRX is my second largest holding. MU is my largest.

The horizontal lines on the right side of the chart below represent the true statistical Closing price distribution of VRX over the last 13 months. The price regions around the spikes should be considered as Sup/Res regions. You should note that VRX is currently trading (with high volume) above an SR region centered at about $15.40 (on a sucky day).

It appears that price is headed toward the next highest SR level around $17. I like to bring in extra income by selling Covered Calls (CCs), so I’ll be looking to see how VRX behaves as it approaches its next resistance level then decide If I should sell those overhead Calls.

FWIW, I never use stop-loss orders -- it’s too easy to get stopped out of a perfectly good position. IMO it’s better to sell CCs when one feels like putting in stop-loss orders and let the market decide whether or not to take the shares. At least you get paid to be taken out. And if you don’t want to be taken out, you can always roll the Calls out and up at relatively low cost.




Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist